Journal of Cataract & Refractive Surgery
Volume 33, Issue 9 , Pages 1550-1558 , September 2007

Clinical pseudophakic cystoid macular edema: Risk factors for development and duration after treatment

,Accepted 7 May 2007.

References 

  1. International Agency for the Prevention of Blindness, under the direction of Sir John Wilson . World Blindness and its Prevention. New York, NY: Oxford University Press; 1980;
  2. National Advisory Eye Council (U.S.) . Vision Research: A National Plan: 1983–1987. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health; 1983;NIH Publication no. 83-2473; vol. 2, pt 3
  3. Wright PL, Wilkinson CP, Balyeat HD, et al. Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol. 1988;106:740–744
  4. Gass JDM, Norton EWD. Follow-up study of cystoid macular edema following cataract extraction. Trans Am Acad Ophthalmol Otolaryngol. 1969;73:665–681discussion by AB Reese, 681–682
  5. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992;36:259–284
  6. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol. 2002;17:167–180
  7. Sivaprasad S, Bunce C, Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev. 2005;25:CD004239
  8. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000;107:2034–2038discussion by AJ Flach, 2039
  9. Singal N, Hopkins J. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone. Can J Ophthalmol. 2004;39:245–250
  10. Pollack A, Leiba H, Bukelman A, et al. The course of diabetic retinopathy following cataract surgery in eyes previously treated by laser photocoagulation. Br J Ophthalmol. 1992;76:228–231
  11. Bradford JD, Wilkinson CP, Bradford RH. Cystoid macular edema following extracapsular cataract extraction and posterior chamber intraocular lens implantation. Retina. 1988;8:161–164
  12. O'Brien PD, Fitzpatrick P, Kilmartin DJ, Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg. 2004;30:839–843
  13. Cremers SL, Ciolino JB, Ferrufino-Ponce ZK, Henderson BA. Objective Assessment of Skills in Intraocular Surgery (OASIS). Ophthalmology. 2005;112:1236–1241
  14. Miami Study Group . Cystoid macular edema in aphakic and pseudophakic eyes. Am J Ophthalmol. 1979;88:45–48
  15. Stark WJ, Worthen DM, Holladay JT, et al. The FDA report on intraocular lenses. Ophthalmology. 1983;90:311–317
  16. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998;96:557–634Available at: http://www.pubmedcentral.nih.gov/tocrender.fcgi?iid=124633. Accessed May 26, 2007
  17. Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB. Cystoid macular edema after phacoemulsification: relationship to blood–aqueous barrier damage and visual acuity. J Cataract Refract Surg. 1999;25:1492–1497
  18. Miyake K, Ota I, Ibaraki N, et al. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol. 2001;119:387–394
  19. Yeh PC, Ramanathan S. Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg. 2002;28:1814–1818
  20. Altıntaş Ö, Yüksel N, Karabaş VL, Demirci G. Cystoid macular edema associated with latanoprost after uncomplicated cataract surgery. Eur J Ophthalmol. 2005;15:158–161
  21. Moroi SE, Gottfredsdottir MS, Schteingart MT, et al. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology. 1999;106:1024–1029
  22. Henry MM, Henry LM, Henry LM. A possible cause of chronic cystic maculopathy. Ann Ophthalmol. 1977;9:455–457
  23. Holekamp NM. Treatment of pseudophakic CME. Ocul Immunol Inflamm. 1998;6:121–123
  24. Milch FA, Yannuzzi LA. Medical and surgical treatment of aphakic cystoid macular edema. Int Ophthalmol Clin. 1987;27(3):205–217
  25. Gass JDM, Norton EWD. Cystoid macular edema and papilledema following cataract extraction; a fluorescein funduscopic and angiographic study. Arch Ophthalmol. 1966;76:646–661
  26. Jaffe NS, Clayman HM, Jaffe MS. Cystoid macular edema after intracapsular and extracapsular cataract extraction with and without an intraocular lens. Ophthalmology. 1982;89:25–29
  27. Percival P. Clinical factors relating to cystoid macular edema after lens implantation. Am Intra-Ocular Implant Soc J. 1981;7:43–45
  28. Jacobson DR, Dellaporta A. Natural history of cystoid macular edema after cataract extraction. Am J Ophthalmol. 1974;77:445–447
  29. Nagpal M, Nagpal K, Nagpal PN. Postcataract cystoid macular edema. Ophthalmol Clin North Am. 2001;14(4):651–659
  30. Ruiz RS, Saatci OA. Visual outcome in pseudophakic eyes with clinical cystoid macular edema. Ophthalmic Surg. 1991;22:190–193
  31. Estafanous MFG, Lowder CY, Meisler DM, Chauhan R. Phacoemulsification cataract extraction and posterior chamber lens implantation in patients with uveitis. Am J Ophthalmol. 2001;131:620–625
  32. Quinn CJ. Cystoid macular edema. Optom Clin. 1996;5:111–130
  33. Tso MOM. Pathology of cystoid macular edema. Ophthalmology. 1982;89:902–915
  34. Krishna R, Meisler DM, Lowder CY, et al. Long-term follow-up of extracapsular cataract extraction and posterior chamber intraocular lens implantation in patients with uveitis. Ophthalmology. 1998;105:1765–1969
  35. Blair NP, Kim SH, Friedlander SM. Cystoid macular edema after ocular surgery. In:  Albert DM,  Jakobiec FA editor. Principles and Practice of Ophthalmology. 2nd ed.. Philadelphia, PA: Saunders; 2000;p. 2080–2088
  36. Onal S, Gozum N, Gucukoglu A. Visual results and complications of posterior chamber intraocular lens implantation after capsular tear during phacoemulsification. Ophthalmic Surg Lasers Imaging. 2004;35:219–224
  37. Frost NA, Sparrow JM, Strong NP, Rosenthal AR. Vitreous loss in planned extracapsular cataract extraction does lead to a poorer visual outcome. Eye. 1995;9:446–451
  38. Balent A, Civerchia LL, Mohamadi P. Visual outcome of cataract extraction and lens implantation complicated by vitreous loss. J Cataract Refract Surg. 1988;14:158–160
  39. Kraff MC, Sanders DR, Jampol LM, et al. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology. 1982;89:885–890
  40. Miyake K. Indomethacin in the treatment of postoperative cystoid macular edema. Surv Ophthalmol. 1984;28:554–568
  41. Burnett J, Tessler H, Isenberg S, Tso MOM. Double-masked trial of fenoprofen sodium: treatment of chronic aphakic cystoid macular edema. Ophthalmic Surg. 1983;14:150–152
  42. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 1987;103:479–486
  43. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991;112:514–519
  44. O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin. 2005;21:1131–1137erratum, 1431–1432
  45. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378–2384
  46. Yannuzzi LA, Klein RM, Wallyn RH, et al. Ineffectiveness of indomethacin in the treatment of chronic cystoid macular edema. Am J Ophthalmol. 1977;84:517–519
  47. Abbasoğlu ÖE, Hoşal B, Tekeli O, Gürsel E. Risk factors for vitreous loss in cataract surgery. Eur J Ophthalmol. 2000;10:227–232
  48. Blomquist PH, Rugwani RM. Visual outcomes after vitreous loss during cataract surgery performed by residents. J Cataract Refract Surg. 2002;28:847–852
  49. Fujishima H, Toda I, Yagi Y, Tsubota K. Quantitative evaluation of postsurgical inflammation by infrared radiation thermometer and laser flare-cell meter. J Cataract Refract Surg. 1994;20:451–454
  50. Jampol LM, Sanders DR, Kraff MC. Prophylaxis and therapy of aphakic cystoid macular edema. Surv Ophthalmol. 1984;28(suppl):535–539

 No author has a financial or proprietary interest in any material or method mentioned.Supported by Research to Prevent Blindness, Massachusetts Lions Foundation, Norman Knight Ophthalmology Fund, Harvard 50th Anniversary Scholars Grant, and Alcon Labs, Inc.

PII: S0886-3350(07)00902-9

doi: 10.1016/j.jcrs.2007.05.013

Journal of Cataract & Refractive Surgery
Volume 33, Issue 9 , Pages 1550-1558 , September 2007

Article Tools